Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Kambiz, Kosari"'
Autor:
Bhupinder Kaur, Yee Hui Yeo, Jeff Liang, Michael Luu, Walid Ayoub, Alexander Kuo, Hirsh Trivedi, Kamya Sankar, Jun Gong, Andrew Hendifar, Arsen Osipov, Kambiz Kosari, Nicholas Nissen, Mazen Noureddin, Amit G. Singal, Ju Dong Yang
Publikováno v:
Gastro Hep Advances, Vol 3, Iss 2, Pp 230-237 (2024)
Background and Aims: The change in hepatocellular carcinoma (HCC) care continuum during the coronavirus disease 2019 (COVID-19) pandemic remains unknown at a national level in the United States. We sought to determine the impact of the pandemic on in
Externí odkaz:
https://doaj.org/article/344988ee4f5e4b03989b5222e9cc73fc
Autor:
Kamya Sankar, Jun Gong, Arsen Osipov, Steven A. Miles, Kambiz Kosari, Nicholas N. Nissen, Andrew E. Hendifar, Ekaterina K. Koltsova, Ju Dong Yang
Publikováno v:
Clinical and Molecular Hepatology, Vol 30, Iss 1, Pp 1-15 (2024)
Liver cancer remains a challenge of global health, being the 4th leading cause of cancer death worldwide. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, and is usually precipitated by chronic viral infections (hepatit
Externí odkaz:
https://doaj.org/article/ff02d2f3ef1c487fa33fd617d82cefc5
Autor:
Michie A. Adjei, Steven A. Wisel, Noriko Ammerman, Ashley Vo, Maha Guindi, Kambiz Kosari, Georgios Voidonikolas, Tsuyoshi Todo, Nicholas N. Nissen, Stanley C. Jordan, Irene K. Kim
Publikováno v:
Transplantation Reports, Vol 8, Iss 3, Pp 100145- (2023)
Although the incidence of acute antibody mediated rejection in liver transplantation is low, the consequences of acute antibody mediated rejection can be devastating, often leading to severe fibrotic changes and early graft loss. Conventional treatme
Externí odkaz:
https://doaj.org/article/a23361af0d6542ddb614f0e90f9bdb5a
Autor:
Rajalakshmi Govalan, Michael Luu, Marie Lauzon, Kambiz Kosari, Joseph C. Ahn, Nicole E Rich, Nicholas Nissen, Lewis R. Roberts, Amit G. Singal, Ju Dong Yang
Publikováno v:
Hepatology Communications, Vol 6, Iss 1, Pp 223-236 (2022)
Prognosis of hepatocellular carcinoma (HCC) could be affected by lack of or delayed therapy. We aimed to characterize the prevalence, correlates, and clinical impact of therapeutic underuse and delay in patients with HCC. Patients with HCC diagnosed
Externí odkaz:
https://doaj.org/article/712d6ece924040768eecc187834a5741
Autor:
Rajalakshmi Govalan, Marie Lauzon, Michael Luu, Joseph C. Ahn, Kambiz Kosari, Tsuyoshi Todo, Irene K. Kim, Mazen Noureddin, Alexander Kuo, Ayoub S. Walid, Vinay Sundaram, Shelly C. Lu, Lewis R. Roberts, Amit G. Singal, Julie K. Heimbach, Vatche G. Agopian, Nicholas Nissen, Ju Dong Yang
Publikováno v:
Liver Cancer, Pp 1-12 (2021)
Introduction: Small studies from outside of the USA suggest excellent outcomes after surgical resection for hepatocellular carcinoma (HCC) with vascular invasion. The study aims to (1) compare overall survival after surgical resection and systemic th
Externí odkaz:
https://doaj.org/article/467b06b0f4aa4d66b2f0c0188fccf32d
Autor:
Na Sun, Ceng Zhang, Yi‐Te Lee, Benjamin V. Tran, Jing Wang, Hyoyong Kim, Junseok Lee, Ryan Y. Zhang, Jasmine J. Wang, Junhui Hu, Zhicheng Zhang, Manaf S. Alsudaney, Kuan‐Chu Hou, Hubert Tang, Tiffany X. Zhang, Icy Y. Liang, Ziang Zhou, Mengxiang Chen, Angela Hsiao‐Jiun Yeh, Wenyuan Li, Xianghong Jasmine Zhou, Helena R. Chang, Steven‐Huy B. Han, Saeed Sadeghi, Richard S. Finn, Sammy Saab, Ronald W. Busuttil, Mazen Noureddin, Walid S. Ayoub, Alexander Kuo, Vinay Sundaram, Buraq Al‐Ghaieb, Juvelyn Palomique, Kambiz Kosari, Irene K. Kim, Tsuyoshi Todo, Nicholas N. Nissen, Maria Lauda Tomasi, Sungyong You, Edwin M. Posadas, James X. Wu, Madhuri Wadehra, Myung‐Shin Sim, Yunfeng Li, Hanlin L. Wang, Samuel W. French, Shelly C. Lu, Lily Wu, Renjun Pei, Li Liang, Ju Dong Yang, Vatche G. Agopian, Hsian‐Rong Tseng, Yazhen Zhu
Publikováno v:
Hepatology. 77:774-788
The sensitivity of current surveillance methods for detecting early-stage hepatocellular carcinoma (HCC) is suboptimal. Extracellular vesicles (EVs) are promising circulating biomarkers for early cancer detection. In this study, we aim to develop an
Autor:
Nabil Noureddin, MD, Ju Dong Yang, MD, Naim Alkhouri, MD, Samantha M. Noreen, PhD, Alice E. Toll, MS, Tsuyoshi Todo, MD, Walid Ayoub, MD, Alexander Kuo, MD, Georgios Voidonikolas, MD, Honore G. Kotler, RN, PhD-c, ACNP, CCTC, Michalyn D. Pelphrey, MSN, Brenda J. Durand, RN, BSN, Kambiz Kosari, MD, Todd V. Brennan, MD, Irene Kim, MD, Andrew S. Klein, MD, Ekihiro Seki, MD, PhD, Nicholas N. Nissen, MD, Shelly C. Lu, MD, Vinay Sundaram, MD, Mazen Noureddin, MD, MHSc
Publikováno v:
Transplantation Direct, Vol 6, Iss 11, p e612 (2020)
Background. Changing opinions on the alcohol abstinence requirement have led to increased liver transplantation (LT) for alcoholic hepatitis (AH). We aimed to determine the trend in LT for AH in the United States and overall and graft survival rates.
Externí odkaz:
https://doaj.org/article/b1a2dc7a66cd424dab25fcc6a3a7588d
Publikováno v:
Hepatobiliary Surgery and Nutrition. 11:931-934
Autor:
Luxi, Chen, John, Davelaar, Srinivas, Gaddam, Kambiz, Kosari, Nicholas, Nissen, George, Chaux, Christopher, Lee, Eric, Vail, Andrew, Hendifar, Jun, Gong, Karen, Reckamp, Arsen, Osipov
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:6-11
Pancreatic metastasis of primary lung adenocarcinoma is a rare occurrence, accounting for EGFR-mutated lung adenocarcinoma with metastases to the pancreas via early application of next-generation sequencing (NGS). The use of NGS early in the patient
Autor:
Joseph C. Ahn, Rajalakshmi Govalan, Lewis R. Roberts, Marie Lauzon, Nicole E. Rich, Kambiz Kosari, Nicholas N. Nissen, Ju Dong Yang, Michael Luu, Amit G. Singal
Publikováno v:
Hepatology Communications
Hepatology Communications, Vol 6, Iss 1, Pp 223-236 (2022)
Hepatology Communications, Vol 6, Iss 1, Pp 223-236 (2022)
Prognosis of hepatocellular carcinoma (HCC) could be affected by lack of or delayed therapy. We aimed to characterize the prevalence, correlates, and clinical impact of therapeutic underuse and delay in patients with HCC. Patients with HCC diagnosed